DoJ Maintains Amarin 'Misplaced' Its Omega-3 Unfair Trade Argument
This article was originally published in The Rose Sheet
Executive Summary
In an amicus opposing Amarin's petition in federal court for an order that the US ITC investigate its fair trade complaint targeting certain omega-3 oil ingredients, DoJ says the drug firm is attempting private enforcement of the FDC Act. The act "commits enforcement exclusively to the federal government to ensure that complex enforcement decisions are made with the benefit of FDA's scientific and regulatory expertise," DoJ argues.